According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are S$13.84 Billion. In 2023 the company made an earning of S$5.63 Billion a decrease over its 2022 earnings that were of S$6.52 Billion. The earnings displayed on this page is the company's Pretax Income.